E-viri
Recenzirano Odprti dostop
  • SCA-1 Labels a Subset of Es...
    Dall, Genevieve V.; Vieusseux, Jessica L.; Korach, Kenneth S.; Arao, Yukitomo; Hewitt, Sylvia C.; Hamilton, Katherine J.; Dzierzak, Elaine; Boon, Wah Chin; Simpson, Evan R.; Ramsay, Robert G.; Stein, Torsten; Morris, Joanne S.; Anderson, Robin L.; Risbridger, Gail P.; Britt, Kara L.

    Stem cell reports, 02/2017, Letnik: 8, Številka: 2
    Journal Article

    Estrogen stimulates breast development during puberty and mammary tumors in adulthood through estrogen receptor-α (ERα). These effects are proposed to occur via ERα+ luminal cells and not the mammary stem cells (MaSCs) that are ERαneg. Since ERα+ luminal cells express stem cell antigen-1 (SCA-1), we sought to determine if SCA-1 could define an ERα+ subset of EpCAM+/CD24+/CD49fhi MaSCs. We show that the MaSC population has a distinct SCA-1+ population that is abundant in pre-pubertal mammary glands. The SCA-1+ MaSCs have less stem cell markers and less in vivo repopulating activity than their SCA-1neg counterparts. However, they express ERα and specifically enter the cell cycle at puberty. Using estrogen-deficient aromatase knockouts (ArKO), we showed that the SCA-1+ MaSC could be directly modulated by estrogen supplementation. Thus, SCA-1 enriches for an ERα+, estrogen-sensitive subpopulation within the CD24+/CD49fhi MaSC population that may be responsible for the hormonal sensitivity of the developing mammary gland. •SCA-1+ delineates ER-positive cells in the CD24+ CD49fhi mammary stem population•SCA-1+ cells have lower repopulation activity•SCA-1+ cells are estrogen responsive Mouse mammary stem cells are thought to be estrogen-receptor negative and receive hormonal influence via estrogen-receptor-positive luminal neighbors. In this article, Britt and colleagues describe a population within the mammary stem cell-enriched compartment that is estrogen-receptor positive and directly responsive to estrogens. This has implications for understanding how aberrant hormone exposure affects breast cancer risk.